Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group LtdfiledCriticalGlaxo Group Ltd
Priority to CR20110473ApriorityCriticalpatent/CR20110473A/en
Publication of CR20110473ApublicationCriticalpatent/CR20110473A/en
La invención se refiere a variantes mejoradas del dominio variable sencillo de inmunoglobulina anti-albúmina de suero DOM7h-14, así como a ligandos y conjugados de fármacos que comprenden dichas variantes, composiciones, ácido nucleicos, vectores y huéspedesThe invention relates to improved variants of the single variable domain of serum anti-albumin immunoglobulin DOM7h-14, as well as ligands and conjugates of drugs comprising said variants, compositions, nucleic acids, vectors and hosts
CR20110473A2011-09-022011-09-02
VARIATIONS OF UNION TO ANTI-ALBÚMINA DE SERERO IMPROVED.
CR20110473A
(en)